PBT fell 31.8% on 19% revenue growth as costs and book outpaced earnings

Management attributes the earnings decline to "exceptional expenses incurred in the first half of the year amounting to around $600k." On Annolyse's historical baseline, both PBT growth and NPAT growth sit clearly below the prior three-period range, and PBT margin compressed to 11.6% versus a historical mean of 28.3%.

The balance sheet expanded sharply: total assets grew 47.2% to NZ$275.8m and total liabilities grew 54.6% to NZ$245.9m, while equity only rose 5.4% to NZ$29.9m. Cash holdings increased to NZ$35.2m. The interim dividend per share was cut 39.6% to 0.33 cents, lifting retained earnings cover materially.

• Even taking the ~NZ$0.6m of disclosed exceptionals at face value, underlying PBT would not fully bridge the NZ$0.7m year-on-year decline, which means cost growth — not just one-offs — outpaced the revenue uplift. For a deposit-taker, this raises a margin-and-scale question rather than a top-line question.
• Returns weakened despite leverage rising. ROE fell to 3.4% from 5.5%, well below the supplied historical mean of 7.8%, while liabilities grew almost ten times faster than equity. The business is funding a much larger book without yet earning a proportional return on it, which is the central economic tension in this result.
• Tax amplified the decline. The effective tax rate of 31.4% sits at the upper edge of the supplied historical range (mean 28.1%), widening the gap between PBT (-31.8%) and NPAT (-37.5%) by 5.7 percentage points. This makes the headline NPAT drop look worse than the underlying operating decline, but it is not the lead story — operating cost pressure is.

The supplied second-half shape figures for FY25 appear to mix scales between subsidiaries and the group, so they are not a reliable seasonal anchor for HY26 and are set aside.

Against the historical baseline, 19.0% revenue growth is below the three-period range of 38.6%–126.6%. This release does not support a view on whether HY26 represents a step-down from that growth trajectory or a temporary slowdown coinciding with the disclosed exceptionals; both interpretations remain open until second-half data lands.

The bigger quality question is whether the disclosed ~NZ$0.6m of exceptional costs actually rebases earnings cleanly. Even if added back in full, PBT would still be roughly flat year-on-year while assets grew 47.2% — meaning underlying earnings yield on the book has compressed. The dividend cut, payout ratio falling to 19.2% from 96.5%, and a relatively higher tax charge together suggest the board is conserving capital while the franchise scales.

This briefing cannot assess the underlying earnings trajectory excluding the disclosed exceptionals because no line-by-line reconciliation or normalised earnings figure was provided.